Glaxo/Novartis JV Wields ‘Power’ Brands, Switches To Spearhead Global Growth
This article was originally published in The Pink Sheet Daily
Executive Summary
Glaxo prioritizes seven “power” brands globally and also will invest in boosting sales of 12 “core” brands in its consumer JV with Novartis, says division head Emma Walmsley. The combination of the two firms’ consumer products puts the JV atop the OTC/wellness market in 36 countries.